CMT Research Foundation
Atlanta, Georgiacmtrf.org
Overview
A patient-led, 501(c)(3) non-profit organization focused on delivering treatments and cures for Charcot-Marie-Tooth (CMT) disease. The foundation funds and invests in scientific research and drug development, identifying and supporting promising projects with a high potential of leading to clinical trials and approved treatments.
Portfolio Companies
5
Website
cmtrf.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| First Atom Therapeutics | May 2025 | Grant | Co-investor |
| Augustine Therapeutics | Mar 2025 | Series A | Co-investor |
| ReviR Therapeutics | Jul 2024 | Series A | Co-investor |
| Augustine Therapeutics | Jun 2024 | Series A | Co-investor |
| Armatus Bio | Nov 2023 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
